A

Acarix AB
STO:ACARIX

Watchlist Manager
Acarix AB
STO:ACARIX
Watchlist
Price: 0.259 SEK 1.37%
Market Cap: kr290.9m

Wall St Price Targets

ACARIX Price Targets Summary
Acarix AB

Wall Street analysts forecast ACARIX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACARIX is 0.408 SEK with a low forecast of 0.404 SEK and a high forecast of 0.42 SEK.

Lowest Forecast
Price Target
0.404 SEK
56% Upside
Average Forecast
Price Target
0.408 SEK
58% Upside
Highest Forecast
Price Target
0.42 SEK
62% Upside
Acarix AB Competitors:
Price Targets
PHUN
Phunware Inc
211% Upside
PXS
Pyxis Tankers Inc
116% Upside
VIBHA
Vibhavadi Medical Center PCL
4% Upside

Revenue
Forecast

N/A
Past Growth
304% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
N/A
Past Growth
304% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

The compound annual growth rate for Revenue over the next 2 years is 304%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ACARIX's stock price target?
Price Target
0.408 SEK

According to Wall Street analysts, the average 1-year price target for ACARIX is 0.408 SEK with a low forecast of 0.404 SEK and a high forecast of 0.42 SEK.

What is the Revenue forecast for Acarix AB?
Projected CAGR
304%

The compound annual growth rate for Revenue over the next 2 years is 304%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett